首页> 外国专利> Extracts from Ginkgo biloba leaves - with high content of flavone glycoside(s) and ginkgolide(s) but with low alkyl phenol(s) content

Extracts from Ginkgo biloba leaves - with high content of flavone glycoside(s) and ginkgolide(s) but with low alkyl phenol(s) content

机译:银杏叶提取物-黄酮苷和银杏内酯含量高,但烷基酚含量低

摘要

Novel extracts from the leaves of Ginkgo biloba are practically free from alkyl phenols, have a high content of flavone glycosides and contain most of the ginkgolides and bilobalide originally present in the leaves. Pref. the extracts contain 14-22 (esp. 16-18) wt.% flavone glycosides, 1.6-3wt.% total ginkgolides A, B, C and J, 1.4-2.7 wt.% bilobalide and less than 10 ppm (esp. less than 1 ppm) alkyl phenols. USE/ADVANTAGE - The extracts promote circulation, inhibit ischaemic damage and aggregation of radical acceptors and thrombocytes. The extracts are esp. useful in the therapy of peripheral and cerebral arterial disorders of the circulation. Removal of the alkyl phenols (which are associated with allergies) is achieved without the need to use the chlorinated hydrocarbons necessary in previous processes and thus the associated risks to the environment and the presence of residues in the pharmaceutical are avoided.
机译:从银杏叶中提取的新型提取物实际上不含烷基酚,黄酮苷含量高,并且含有最初存在于叶中的大多数银杏内酯和银杏内酯。首选提取物中含有14-22(尤其是16-18)wt。%的黄酮苷,1.6-3 wt。%的总银杏内酯A,B,C和J,1.4-2.7 wt。%的银杏内酯和少于10 ppm(尤其是少于小于1 ppm)的烷基酚。使用/优势-提取物促进血液循环,抑制缺血性损伤以及自由基受体和血小板的聚集。提取物特别是。可用于治疗周围和脑动脉循环障碍。无需使用先前工艺中必需的氯代烃即可去除烷基酚(与过敏相关),因此避免了对环境的相关风险以及药物中残留物的存在。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号